Table 6.
Subgroup analyses (categorized by types of adenomyosis) of patients with atosiban or without
| Focal adenomyosis (n = 216) | Diffuse adenomyosis (n = 100) | |||||
|---|---|---|---|---|---|---|
| Parameters |
Atosiban (n = 102) |
Control (n = 114) |
p value |
Atosiban (n = 55) |
Control (n = 45) |
p value |
| Age (years) | 37.3 ± 4.5 | 38.0 ± 3.7 | 0.213 | 39.0 ± 3.8 | 38.7 ± 3.9 | 0.685 |
| Body mass index (kg/m2) | 24.0 ± 4.0 | 23.5 ± 4.3 | 0.398 | 23.2 ± 3.4 | 23.8 ± 4.3 | 0.382 |
| Infertility duration (years) | 4.4 ± 3.1 | 5.3 ± 3.3 | 0.040 | 5.0 ± 3.5 | 5.4 ± 4.4 | 0.596 |
| Previous IVF attempts (n) | 2.7 ± 2.4 | 3.1 ± 2.4 | 0.200 | 3.2 ± 2.7 | 3.3 ± 2.2 | 0.952 |
| Primary infertility (%) | 49.0%(50/102) | 50.9%(58/114) | 0.785 | 45.5%(25/55) | 37.8%(17/45) | 0.439 |
| FSH (IU/L) | 5.7 ± 3.0 | 5.1 ± 3.2 | 0.150 | 4.7 ± 2.0 | 5.3 ± 2.1 | 0.181 |
| Anti-Müllerian hormone (ng/ml) | 4.03 ± 4.02 | 3.43 ± 2.93 | 0.217 | 2.18 ± 1.88 | 2.83 ± 2.08 | 0.104 |
| Endometrial thickness (mm) | 11.8 ± 2.2 | 11.8 ± 2.2 | 0.948 | 11.3 ± 2.4 | 11.1 ± 2.2 | 0.674 |
| ET day (%) | 0.162 | 0.562 | ||||
| Day 3 ET | 52.0%(53/102) | 61.4%(70/114) | 72.7%(40/55) | 77.8%(35/45) | ||
| Day 5 ET | 48.0%(49/102) | 38.6%(44/114) | 27.3%(15/55) | 22.2%(10/45) | ||
| At least one top-quality embryos transferred (%) | 80.4%(82/102) | 77.2%(88/114) | 0.566 | 76.4%(42/55) | 82.2%(37/45) | 0.474 |
| Biochemical pregnancy rate (%) | 66.7%(68/102) | 60.5%(69/114) | 0.350 | 43.6%(24/55) | 15.6%(7/45) | 0.003 |
| Clinical pregnancy rate (%) | 57.8%(59/102) | 59.6%(68/114) | 0.788 | 38.2%(21/55) | 13.3%(6/45) | 0.005 |
| Ongoing pregnancy rate (%) | 52.0%(53/102) | 46.5%(53/114) | 0.422 | 36.4%(20/55) | 11.1%(5/45) | 0.004 |
| Live birth rate (%) | 50.0%(51/102) | 43.9%(50/114) | 0.367 | 32.7%(18/55) | 11.1%(5/45) | 0.011 |
| Miscarriage rate (%) | 13.6%(8/59) | 26.5%(18/68) | 0.072 | 14.3%(3/21) | 16.7%(1/6) | 0.885 |
| Early miscarriage rate (%) | 10.2%(6/59) | 22.1%(15/68) | 0.072 | 4.8%(1/21) | 16.7%(1/6) | 0.326 |
| Late miscarriage rate (%) | 3.4%(2/59) | 4.4%(3/68) | 0.768 | 9.5%(2/21) | 0.0%(0/6) | 0.432 |
Data are presented as the mean ± standard deviation and % (n)
IVF, in vitro fertilization; FSH, follicular stimulating hormone; ET, embryo transfer